This study, called ROPES, is looking at ways to reduce the amount of opioid pain medication men need after robotic-assisted laparoscopic prostatectomy (RALP), a surgery to remove the prostate. Researchers are comparing different pain management plans after surgery. One plan includes a small opioid prescription right away, while another uses a multimodal analgesia pathway (a combination of pain relief methods) without an automatic opioid prescription, but you can call for opioids if needed. They are also looking at how much opioid was used before these new plans were put in place. The main goal is to see if these new approaches can lower the amount of opioids used after you leave the hospital. Men aged 45 and older undergoing RALP at Brigham and Women's Hospital or Brigham & Women's Faulkner Hospital can join, as long as they don't have certain health conditions like chronic kidney disease or regular opioid use. The study is currently unclear on its recruitment status.

Study design

This is an interventional study planning to enroll 300 men. It is an open-label, randomized study, meaning both you and your doctors will know which treatment group you are in.

What's involved

You would be counseled on post-operative pain management and then randomized to one of the pain management pathways after your robotic-assisted laparoscopic prostatectomy.

Compensation

Not stated in the trial record.

Follow-up

Your opioid consumption will be measured 1-2 weeks after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.